SELL YOUR PRODUCTS
*mymedicalexpo  
English
video corpo

Monoclonal antibody reagent CA19-9 - Antibodies
for cancersCA 19-9

monoclonal antibody reagent
monoclonal antibody reagent
Add to favorites
Compare this product
 

Characteristics

Type
monoclonal antibody
Applications
for cancers
Tested parameter
CA 19-9

Description

The CanAg CA19-9 EIA is based on a mouse monoclonal antibody, C192, highly specific for the sialyl Lewisa epitope, also known as CA19-9 antigen1. In adults, the epitope is typically expressed in trace amounts on mucosal cells of gastrointestinal epithelia. In patients with malignant disease, the epitope may appear associated with high molecular weight mucin in blood. Assays for CA19-9 are frequently used to monitor gastrointestinal malignancies such as pancreatic, gall bladder, gastric, and colorectal cancers2, 3. References Rye P. D. et al., (1998) Summary report on the ISOBM TD-6 workshop: Analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreaux, Switzerland; September 19-24 1997. Tumor Biol. 19:390-420. Eskelinen M., and Haglund U. (1999) Developments in serologic detection of human pancreatic adenocarcinoma. Scand J Gastroenterol. 34: 833-844. Hammarström S., and Stigbrand T. (2002) Gastric Cancer. In “Tumor markers, Physiology, Pathobiology, Technology and Clinical Applications” Eds. Diamandis E. P. et al., AACC Press, Washington pp 375-379.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.